APOC-III-directed RNA Interaction [EPC] - N0000194144

Pharmacologic Code	N0000194144
Pharmacologic Name	APOC-III-directed RNA Interaction
Pharmacologic Uses	APOC-III-directed antisense oligonucleotide (ASO) apolipoprotein C-III (apoC-III)-directed small interfering ribonucleic acid (siRNA)
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 2 products whose active ingredient are classified under the same pharmacologic class APOC-III-directed RNA Interaction [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	71860-101	Tryngolza	Non-Proprietary Name: Olezarsen Sodium	Injection, Solution	Subcutaneous	Ionis Pharmaceuticals, Inc.	ACTIVE
	71860-102	Tryngolza	Non-Proprietary Name: Olezarsen Sodium	Injection, Solution	Subcutaneous	Ionis Pharmaceuticals, Inc.	ACTIVE